MetricSide LogoMetricSide
Learn
  1. Home
  2. Companies
  3. Healthcare
  4. BMY
OverviewMetricsPricesRevenue & ProfitAssets & LiabilitiesCash FlowMarginsPrice RatiosOthers
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

Legal & Contact

  • Terms of Service
  • Privacy Policy
  • Contact Us
Not Financial Advice: MetricSide is a data aggregation and visualization tool. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. All data is provided for informational and educational purposes only. Past performance is not indicative of future results. Always consult a qualified financial professional before making investment decisions. Data accuracy is not guaranteed — verify critical information against official sources.

© 2026 MetricSide. All rights reserved.

Bristol-Myers Squibb (BMY) Financial Metrics 2020-2026

Key metrics and charts across all fundamental categories.

Prices

Stock price and market valuation

Stock Price
$63.06
36.2%
Market Cap
$128.77B
36.7%

BMY trades at $63.06, a 36.2% increase year-over-year. Market capitalization stands at $128.77B, up 36.7% from the prior year. Track BMY price trends and market cap history to understand how the market values this company over time.

Stock Price
How the market values the company over time
Market Cap
Total equity value as determined by the market

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares across quarters

TTM Revenue
$49.19B
3.1%
Q. Revenue
$12.97B
TTM EBITDA
$19.55B
12.0%
TTM Op. Income
$16.37B
4.2%
Q. Op. Income
$4.46B
TTM Net Income
$9.28B
83.8%
Q. Net Income
$3.32B
EPS
$1.62
Shares Out.
$2.04B
0.3%
$49.19B in TTM revenue grew 3.1% YoY, reaching $12.97B last quarter. TTM EBITDA of $19.55B and TTM operating income of $16.37B show growth is flowing through to the bottom line. TTM net income of $9.28B means revenue is converting into profit.
TTM Revenue
Reveals whether the core business is growing or shrinking
Quarterly Revenue
Highlights seasonal patterns and short-term momentum
TTM EBITDA
Shows if underlying operating profitability is improving
Quarterly EBITDA
Tracks near-term operating profitability trends
TTM Operating Income
Smoothed operating profit over the past four quarters
Quarterly Operating Income
Profit from core operations before financing costs
TTM Net Income
The bottom line — is the company making more money?
Quarterly Net Income
Short-term profit after all expenses and taxes
EPS
Earnings per share — profit attributable to each share
Shares Outstanding
Declining means buybacks benefit remaining holders

Assets & Liabilities

Assets, cash, debt, book value, and leverage

Total Assets
$87.63B
Cash
$8.72B
Long-Term Debt
$42.09B
Book Value
$22.32B
D/E Ratio
1.9
Debt/EBITDA
8.3
With $87.63B in assets and $42.09B in long-term debt, D/E is 1.9and book value is $22.32B — moderate leverage.
Total Assets
Expanding asset base can indicate business growth
Cash & Equivalents
Shows liquidity available for opportunities or downturns
Long-Term Debt
Declining debt trend is generally positive
Book Value (Equity)
Growing book value signals intrinsic value creation
Debt / Equity
Lower means less reliance on borrowed money
Debt / EBITDA
Below 2x is conservative; above 4x is high

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow
$3.39B
TTM Free Cash Flow
$11.44B
21.5%
FCF Margin
23.3%
FCF / Net Income
1.2
TTM FCF of $11.44B on $3.39B in operating cash flow. The FCF / Net Income ratio of 1.2x means free cash flow covers net income — earnings are backed by cash.
Operating Cash Flow
Cash generated from core business operations
Free Cash Flow
Cash the business generates after maintaining itself
FCF Margin (TTM %)
TTM FCF / TTM Revenue — 10%+ signals a capital-efficient business model
FCF / Net Income (TTM)
TTM FCF / TTM Net Income — above 1 means earnings are backed by real cash

Margins

Profit margins across the income statement

Gross Margin
71.3%
1.7%
EBITDA Margin
39.0%
Op. Margin
34.4%
8.3%
Net Margin
25.6%
139.5%
Op. margin of 34.4% is down 3.1% YoY — costs are rising relative to revenue. Net margin at 25.6% and gross margin of 71.3% show how much of each revenue dollar survives to profit.
Gross Margin (%)
Revenue left after direct cost of goods sold
EBITDA Margin (%)
Operating profitability independent of capital structure
Operating & Net Margins (%)
How much of each dollar becomes profit

Price Ratios

Valuation multiples — is the company cheap or expensive?

P/E Ratio
13.9x
P/S Ratio
2.6x
P/B Ratio
5.8x
At 13.9x P/E, the stock trades below typical market levels. P/S of 2.6x and P/B of 5.8x provide additional context. Use the growth and margin sections to judge whether the multiple is justified.
P/E Ratio
Higher suggests growth expectations; lower may signal undervaluation
P/S Ratio
Useful when earnings are volatile or negative
P/B Ratio
Below 1 means trading below accounting book value
EV / EBITDA
Lower multiple often signals better value
FCF Yield (TTM %)
TTM FCF / Market Cap — compare to bond yields
Earnings Yield (%)
Earnings return at current price — inverse of P/E

Others

Return ratios, efficiency, and credit metrics

ROE
41.6%
ROA
10.6%
Asset Turnover
0.6
Rev/Share
$24.09
ROE of 41.6% signals a durable competitive advantage — well above market averages. ROA of 10.6% shows how efficiently management uses assets to generate profit. Revenue per share at $24.087 removes dilution effects from top-line growth.
Return on Equity (ROE)
15%+ consistently signals a durable competitive advantage
Return on Assets (ROA)
How well management uses assets to generate profit
Asset Turnover
How efficiently assets generate each dollar of sales
Revenue per Share
Per-share revenue growth adjusted for dilution
Interest Coverage
How comfortably the company covers interest payments